Back to Results
First PageMeta Content
Pharmacology / Aromatase inhibitors / Södertälje Municipality / Anastrozole / Fulvestrant / Virginia Commonwealth University / Pharmaceutical drug / Tamoxifen / Chemistry / AstraZeneca / Organic chemistry


Approved by the Vice-Chairperson – October 27, 2010 VOLUNTARY COMPLIANCE UNDERTAKING OF ASTRAZENECA CANADA INC. TO THE PATENTED MEDICINE PRICES REVIEW BOARD
Add to Reading List

Document Date: 2013-01-18 14:33:28


Open Document

File Size: 66,29 KB

Share Result on Facebook

Company

ASTRAZENECA CANADA INC. / AstraZeneca AB / /

Country

Sweden / Canada / /

Currency

USD / /

Event

Patent Issuance / /

IndustryTerm

drug product / treatment of locally advanced or metastatic breast cancer / appropriate comparator drug products / /

Organization

PMPRB’s Human Drug Advisory Panel / CANADA INC / PATENTED MEDICINE PRICES REVIEW BOARD / Patented Medicines Prices Review Board / /

Person

Marion E. McCourt / /

Position

Company Officer / President and CEO / Vice-Chairperson / /

SocialTag